US 7129332
Anti-EGFRvIII scFvs with improved cytotoxicity and yield, immunotoxins based thereon, and methods of use thereof
granted A61KA61K2039/505A61K47/6849
Quick answer
US patent 7129332 (Anti-EGFRvIII scFvs with improved cytotoxicity and yield, immunotoxins based thereon, and methods of use thereof) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Oct 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Oct 31 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K2039/505, A61K47/6849, A61P, A61P35/00